[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 538)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":538,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.89,"TPM_sd":3.97,"TPM_min":0,"TPM_25th_percentile":1.36,"TPM_median":2.63,"TPM_75th_percentile":4.84,"TPM_max":28.36},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 168)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":168,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.76,"TPM_sd":5.92,"TPM_min":0.03,"TPM_25th_percentile":0.9,"TPM_median":2.82,"TPM_75th_percentile":6.34,"TPM_max":36.98},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 40)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":40,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.4,"TPM_sd":2.53,"TPM_min":0.08,"TPM_25th_percentile":0.4,"TPM_median":0.58,"TPM_75th_percentile":1.37,"TPM_max":14.83},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.7,"TPM_sd":5.9,"TPM_min":0,"TPM_25th_percentile":1.34,"TPM_median":2.09,"TPM_75th_percentile":2.91,"TPM_max":35.71},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.13,"TPM_sd":0.72,"TPM_min":0.18,"TPM_25th_percentile":0.62,"TPM_median":1.15,"TPM_75th_percentile":1.71,"TPM_max":1.98},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.81,"TPM_sd":11.43,"TPM_min":0.43,"TPM_25th_percentile":0.62,"TPM_median":0.98,"TPM_75th_percentile":2.15,"TPM_max":36.33},{"x_label":"Choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":25,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus papilloma","GTEx_tissue_subgroup":"","EFO":"EFO_1000177","MONDO":"MONDO_0009837","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.8,"TPM_sd":1.81,"TPM_min":0.16,"TPM_25th_percentile":0.79,"TPM_median":1.09,"TPM_75th_percentile":2.49,"TPM_max":8.19},{"x_label":"Clear cell sarcoma of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Clear cell sarcoma of the kidney","GTEx_tissue_subgroup":"","EFO":"EFO_0000350","MONDO":"MONDO_0005006","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.32,"TPM_sd":0.73,"TPM_min":1.02,"TPM_25th_percentile":1.91,"TPM_median":2.23,"TPM_75th_percentile":2.84,"TPM_max":3.3},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 12)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.23,"TPM_sd":12.4,"TPM_min":0.43,"TPM_25th_percentile":1.05,"TPM_median":2.82,"TPM_75th_percentile":12.07,"TPM_max":37.02},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 17)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":17,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.45,"TPM_sd":0.42,"TPM_min":0.06,"TPM_25th_percentile":0.17,"TPM_median":0.31,"TPM_75th_percentile":0.69,"TPM_max":1.46},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.83,"TPM_sd":1.28,"TPM_min":0.1,"TPM_25th_percentile":0.14,"TPM_median":0.23,"TPM_75th_percentile":0.92,"TPM_max":2.74},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.07,"TPM_sd":6.42,"TPM_min":0,"TPM_25th_percentile":0.78,"TPM_median":1.57,"TPM_75th_percentile":3.79,"TPM_max":35.27},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.43,"TPM_sd":1.17,"TPM_min":0.01,"TPM_25th_percentile":0.11,"TPM_median":0.14,"TPM_75th_percentile":0.26,"TPM_max":6.46},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.81,"TPM_sd":2.14,"TPM_min":0.88,"TPM_25th_percentile":1.11,"TPM_median":2.51,"TPM_75th_percentile":4.2,"TPM_max":5.32},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.7,"TPM_sd":1.16,"TPM_min":0.01,"TPM_25th_percentile":0.12,"TPM_median":0.34,"TPM_75th_percentile":0.82,"TPM_max":8.92},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.36,"TPM_sd":0.65,"TPM_min":0.72,"TPM_25th_percentile":0.87,"TPM_median":1.09,"TPM_75th_percentile":1.77,"TPM_max":2.63},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 64)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.4,"TPM_sd":0.99,"TPM_min":0.02,"TPM_25th_percentile":0.13,"TPM_median":0.23,"TPM_75th_percentile":0.35,"TPM_max":7.95},{"x_label":"Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.11,"TPM_sd":2.18,"TPM_min":0.08,"TPM_25th_percentile":0.63,"TPM_median":1.03,"TPM_75th_percentile":2.95,"TPM_max":8.98},{"x_label":"Ganglioneuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 26)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":26,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"GMKF","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.18,"TPM_sd":2.64,"TPM_min":0.18,"TPM_25th_percentile":0.64,"TPM_median":0.92,"TPM_75th_percentile":2.64,"TPM_max":10.47},{"x_label":"Ganglioneuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.75,"TPM_sd":2.39,"TPM_min":0.12,"TPM_25th_percentile":0.62,"TPM_median":2.29,"TPM_75th_percentile":4.27,"TPM_max":8.98},{"x_label":"Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Germinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.06,"TPM_sd":6.69,"TPM_min":0.55,"TPM_25th_percentile":1.32,"TPM_median":2.9,"TPM_75th_percentile":4.47,"TPM_max":20.79},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 19)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":19,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.24,"TPM_sd":2.37,"TPM_min":0.02,"TPM_25th_percentile":0.1,"TPM_median":0.25,"TPM_75th_percentile":0.68,"TPM_max":8.16},{"x_label":"Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Hemangioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016748","MONDO":"MONDO_0016748","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.36,"TPM_sd":0.22,"TPM_min":0.16,"TPM_25th_percentile":0.26,"TPM_median":0.31,"TPM_75th_percentile":0.42,"TPM_max":0.68},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 95)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":95,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.19,"TPM_sd":8.72,"TPM_min":0.07,"TPM_25th_percentile":1.01,"TPM_median":2.11,"TPM_75th_percentile":5.5,"TPM_max":57.89},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 29)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":29,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.82,"TPM_sd":1.98,"TPM_min":0.01,"TPM_25th_percentile":0.34,"TPM_median":1.13,"TPM_75th_percentile":2.82,"TPM_max":7.29},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.42,"TPM_sd":0.38,"TPM_min":0.15,"TPM_25th_percentile":0.27,"TPM_median":0.28,"TPM_75th_percentile":0.36,"TPM_max":1.18},{"x_label":"Langerhans Cell histiocytosis  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Langerhans Cell histiocytosis","GTEx_tissue_subgroup":"","EFO":"EFO_1000318","MONDO":"MONDO_0018310","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.18,"TPM_sd":0.58,"TPM_min":0.44,"TPM_25th_percentile":0.91,"TPM_median":1.2,"TPM_75th_percentile":1.32,"TPM_max":2.02},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 329)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":329,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.47,"TPM_sd":0.87,"TPM_min":0,"TPM_25th_percentile":0.13,"TPM_median":0.23,"TPM_75th_percentile":0.43,"TPM_max":7.69},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.66,"TPM_sd":0.88,"TPM_min":0.06,"TPM_25th_percentile":0.14,"TPM_median":0.6,"TPM_75th_percentile":0.7,"TPM_max":3.53},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.85,"TPM_sd":0.8,"TPM_min":0.33,"TPM_25th_percentile":0.39,"TPM_median":0.45,"TPM_75th_percentile":1.11,"TPM_max":1.77},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 206)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":206,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.48,"TPM_sd":10.86,"TPM_min":0.12,"TPM_25th_percentile":1.2,"TPM_median":1.84,"TPM_75th_percentile":3.31,"TPM_max":115.46},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.92,"TPM_sd":2.9,"TPM_min":0,"TPM_25th_percentile":0.22,"TPM_median":0.29,"TPM_75th_percentile":0.46,"TPM_max":16.37},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 304)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":304,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.6,"TPM_sd":2.77,"TPM_min":0.1,"TPM_25th_percentile":1.68,"TPM_median":3,"TPM_75th_percentile":4.91,"TPM_max":21.06},{"x_label":"Neuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 183)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":183,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"GMKF","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.37,"TPM_sd":2.35,"TPM_min":0.14,"TPM_25th_percentile":1.85,"TPM_median":2.98,"TPM_75th_percentile":4.78,"TPM_max":19.81},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.95,"TPM_sd":3.26,"TPM_min":0.1,"TPM_25th_percentile":1.54,"TPM_median":3.06,"TPM_75th_percentile":5.41,"TPM_max":21.06},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.37,"TPM_sd":0.41,"TPM_min":0.02,"TPM_25th_percentile":0.15,"TPM_median":0.24,"TPM_75th_percentile":0.39,"TPM_max":1.67},{"x_label":"Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Non-germinomatous germ cell tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.29,"TPM_sd":4.38,"TPM_min":0.13,"TPM_25th_percentile":0.69,"TPM_median":4.47,"TPM_75th_percentile":8.06,"TPM_max":8.09},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.52,"TPM_sd":0.89,"TPM_min":0.02,"TPM_25th_percentile":0.15,"TPM_median":0.32,"TPM_75th_percentile":0.49,"TPM_max":4.19},{"x_label":"Osteosarcoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 87)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":87,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Osteosarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000637","MONDO":"MONDO_0009807","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.11,"TPM_sd":3.86,"TPM_min":0.45,"TPM_25th_percentile":1.47,"TPM_median":2.15,"TPM_75th_percentile":3.43,"TPM_max":32.2},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.87,"TPM_sd":8.57,"TPM_min":0.26,"TPM_25th_percentile":1.01,"TPM_median":2.22,"TPM_75th_percentile":4.06,"TPM_max":25.01},{"x_label":"Rhabdoid tumor of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 64)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Rhabdoid tumor of the kidney","GTEx_tissue_subgroup":"","EFO":"EFO_1000512","MONDO":"MONDO_0002729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.99,"TPM_sd":1.9,"TPM_min":0,"TPM_25th_percentile":1.42,"TPM_median":2.69,"TPM_75th_percentile":4.42,"TPM_max":8.13},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.3,"TPM_sd":1.34,"TPM_min":0.09,"TPM_25th_percentile":0.64,"TPM_median":0.95,"TPM_75th_percentile":1.33,"TPM_max":4.16},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.45,"TPM_sd":0.35,"TPM_min":0.1,"TPM_25th_percentile":0.2,"TPM_median":0.39,"TPM_75th_percentile":0.56,"TPM_max":1.73},{"x_label":"Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Subependymal Giant Cell Astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016693","MONDO":"MONDO_0016693","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.66,"TPM_sd":0.4,"TPM_min":0.23,"TPM_25th_percentile":0.48,"TPM_median":0.56,"TPM_75th_percentile":0.71,"TPM_max":1.31},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.96,"TPM_sd":0.9,"TPM_min":0.16,"TPM_25th_percentile":0.28,"TPM_median":0.6,"TPM_75th_percentile":1.58,"TPM_max":2.29},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 124)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":124,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.7,"TPM_sd":3.82,"TPM_min":0.36,"TPM_25th_percentile":2.57,"TPM_median":4.92,"TPM_75th_percentile":7.72,"TPM_max":20.45},{"x_label":"Acute Myeloid Leukemia  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 147)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":147,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.44,"TPM_sd":8.05,"TPM_min":1.64,"TPM_25th_percentile":9.92,"TPM_median":14.82,"TPM_75th_percentile":19.06,"TPM_max":55.63},{"x_label":"Adrenocortical Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 77)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":77,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Adrenocortical Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000796","MONDO":"MONDO_0006639","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.96,"TPM_sd":1.03,"TPM_min":0.02,"TPM_25th_percentile":0.28,"TPM_median":0.51,"TPM_75th_percentile":1.44,"TPM_max":5.41},{"x_label":"Bladder Urothelial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 405)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":405,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Bladder Urothelial Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0006544","MONDO":"MONDO_0005611","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.65,"TPM_sd":3.39,"TPM_min":0.24,"TPM_25th_percentile":1.67,"TPM_median":2.89,"TPM_75th_percentile":4.74,"TPM_max":32.21},{"x_label":"Breast Invasive Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 1088)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":1088,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Breast Invasive Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000307","MONDO":"MONDO_0006256","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.6,"TPM_sd":2.84,"TPM_min":0.06,"TPM_25th_percentile":1.67,"TPM_median":2.81,"TPM_75th_percentile":4.72,"TPM_max":23.46},{"x_label":"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 304)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":304,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000162","MONDO":"MONDO_0006143","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.16,"TPM_sd":2.93,"TPM_min":0.46,"TPM_25th_percentile":3.06,"TPM_median":4.66,"TPM_75th_percentile":6.54,"TPM_max":22.32},{"x_label":"Cholangiocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 35)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":35,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Cholangiocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0005221","MONDO":"MONDO_0019087","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.56,"TPM_sd":0.89,"TPM_min":0.21,"TPM_25th_percentile":0.88,"TPM_median":1.32,"TPM_75th_percentile":2.07,"TPM_max":3.49},{"x_label":"Chromophobe renal cell carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 65)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":65,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Chromophobe renal cell carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000335","MONDO":"MONDO_0017885","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.31,"TPM_sd":0.45,"TPM_min":0.02,"TPM_25th_percentile":0.11,"TPM_median":0.18,"TPM_75th_percentile":0.28,"TPM_max":2.56},{"x_label":"Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 288)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":288,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Colon Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1001949","MONDO":"MONDO_0002271","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.49,"TPM_sd":5.86,"TPM_min":0.69,"TPM_25th_percentile":3.01,"TPM_median":4.39,"TPM_75th_percentile":6.57,"TPM_max":77.56},{"x_label":"Cutaneous Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 102)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":102,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Cutaneous Melanoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000389","MONDO":"MONDO_0005012","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.25,"TPM_sd":2.09,"TPM_min":0.04,"TPM_25th_percentile":0.72,"TPM_median":1.66,"TPM_75th_percentile":3.34,"TPM_max":13.44},{"x_label":"Esophageal Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 158)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":158,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Esophageal Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002916","MONDO":"MONDO_0019086","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.57,"TPM_sd":5.34,"TPM_min":0.27,"TPM_25th_percentile":3.94,"TPM_median":6.16,"TPM_75th_percentile":9.26,"TPM_max":31.38},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 152)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":152,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.82,"TPM_sd":1.37,"TPM_min":0.19,"TPM_25th_percentile":0.97,"TPM_median":1.52,"TPM_75th_percentile":2.2,"TPM_max":9.49},{"x_label":"Head and Neck Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":498,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Head and Neck Squamous Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000181","MONDO":"MONDO_0010150","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.58,"TPM_sd":2.82,"TPM_min":0.1,"TPM_25th_percentile":1.73,"TPM_median":2.91,"TPM_75th_percentile":4.49,"TPM_max":24.82},{"x_label":"Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 369)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":369,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Hepatocellular Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000182","MONDO":"MONDO_0007256","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.82,"TPM_sd":0.84,"TPM_min":0.04,"TPM_25th_percentile":0.28,"TPM_median":0.52,"TPM_75th_percentile":0.99,"TPM_max":5.44},{"x_label":"Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 507)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":507,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.03,"TPM_sd":1.34,"TPM_min":0.07,"TPM_25th_percentile":0.35,"TPM_median":0.57,"TPM_75th_percentile":1.08,"TPM_max":11.25},{"x_label":"Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 510)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":510,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lung Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000571","MONDO":"MONDO_0005061","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.4,"TPM_sd":2.28,"TPM_min":0.2,"TPM_25th_percentile":1.19,"TPM_median":1.75,"TPM_75th_percentile":2.77,"TPM_max":23.18},{"x_label":"Lung Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":498,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lung Squamous Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000708","MONDO":"MONDO_0005097","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.45,"TPM_sd":2.1,"TPM_min":0.23,"TPM_25th_percentile":1.96,"TPM_median":3.1,"TPM_75th_percentile":4.28,"TPM_max":13.91},{"x_label":"Lymphoid Neoplasm Diffuse Large B-cell Lymphoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 47)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":47,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lymphoid Neoplasm Diffuse Large B-cell Lymphoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000403","MONDO":"MONDO_0018905","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.37,"TPM_sd":3.01,"TPM_min":0.42,"TPM_25th_percentile":2.21,"TPM_median":3.27,"TPM_75th_percentile":5.94,"TPM_max":12.01},{"x_label":"Mesothelioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 86)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":86,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Mesothelioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000588","MONDO":"MONDO_0005065","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.04,"TPM_sd":1.19,"TPM_min":0.35,"TPM_25th_percentile":1.36,"TPM_median":1.88,"TPM_75th_percentile":2.47,"TPM_max":7.21},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":373,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.98,"TPM_sd":1.37,"TPM_min":0.23,"TPM_25th_percentile":1.06,"TPM_median":1.63,"TPM_75th_percentile":2.49,"TPM_max":11.78},{"x_label":"Pancreatic Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":177,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Pancreatic Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000044","MONDO":"MONDO_0006047","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.51,"TPM_sd":0.84,"TPM_min":0.1,"TPM_25th_percentile":0.95,"TPM_median":1.32,"TPM_75th_percentile":1.96,"TPM_max":4.54},{"x_label":"Pheochromocytoma and Paraganglioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":177,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Pheochromocytoma and Paraganglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0020005","MONDO":"MONDO_0035540","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.39,"TPM_sd":0.28,"TPM_min":0.05,"TPM_25th_percentile":0.19,"TPM_median":0.3,"TPM_75th_percentile":0.52,"TPM_max":2.01},{"x_label":"Prostate Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 494)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":494,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Prostate Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000673","MONDO":"MONDO_0005082","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.52,"TPM_sd":0.51,"TPM_min":0.03,"TPM_25th_percentile":0.25,"TPM_median":0.4,"TPM_75th_percentile":0.61,"TPM_max":4.87},{"x_label":"Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 92)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":92,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Rectum Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0005631","MONDO":"MONDO_0002169","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.44,"TPM_sd":2.84,"TPM_min":0.98,"TPM_25th_percentile":3.18,"TPM_median":4.67,"TPM_75th_percentile":7.55,"TPM_max":13.95},{"x_label":"Renal Clear Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 527)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":527,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Renal Clear Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000349","MONDO":"MONDO_0005005","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.34,"TPM_sd":0.95,"TPM_min":0.01,"TPM_25th_percentile":0.74,"TPM_median":1.18,"TPM_75th_percentile":1.74,"TPM_max":10.35},{"x_label":"Renal Papillary Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 286)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":286,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Renal Papillary Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000640","MONDO":"MONDO_0017884","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.63,"TPM_sd":0.64,"TPM_min":0.02,"TPM_25th_percentile":0.25,"TPM_median":0.46,"TPM_75th_percentile":0.82,"TPM_max":5.68},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 258)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":258,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.52,"TPM_sd":3.04,"TPM_min":0.05,"TPM_25th_percentile":1.57,"TPM_median":2.5,"TPM_75th_percentile":4.62,"TPM_max":18.43},{"x_label":"Stomach Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":373,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Stomach Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000503","MONDO":"MONDO_0005036","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.5,"TPM_sd":7.07,"TPM_min":0.28,"TPM_25th_percentile":2.63,"TPM_median":4.35,"TPM_75th_percentile":6.72,"TPM_max":122.73},{"x_label":"Testicular Germ Cell Tumor  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 148)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":148,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Testicular Germ Cell Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1000566","MONDO":"MONDO_0010108","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.38,"TPM_sd":2.37,"TPM_min":0.42,"TPM_25th_percentile":2.68,"TPM_median":3.86,"TPM_75th_percentile":5.66,"TPM_max":11.11},{"x_label":"Thymoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 118)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":118,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Thymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000581","MONDO":"MONDO_0006456","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.47,"TPM_sd":2.1,"TPM_min":0.46,"TPM_25th_percentile":1.78,"TPM_median":3.17,"TPM_75th_percentile":4.92,"TPM_max":12.43},{"x_label":"Thyroid Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 501)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":501,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Thyroid Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002892","MONDO":"MONDO_0015075","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.76,"TPM_sd":0.39,"TPM_min":0.08,"TPM_25th_percentile":0.45,"TPM_median":0.7,"TPM_75th_percentile":1.02,"TPM_max":2.59},{"x_label":"Uterine Carcinosarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 56)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":56,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uterine Carcinosarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000613","MONDO":"MONDO_0006485","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.12,"TPM_sd":1.36,"TPM_min":1.01,"TPM_25th_percentile":2.06,"TPM_median":2.95,"TPM_75th_percentile":4.04,"TPM_max":5.85},{"x_label":"Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 178)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":178,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uterine Corpus Endometrial Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0007532","MONDO":"MONDO_0000553","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.06,"TPM_sd":3.35,"TPM_min":0.04,"TPM_25th_percentile":1.42,"TPM_median":2.28,"TPM_75th_percentile":3.68,"TPM_max":26.79},{"x_label":"Uveal Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 79)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":79,"Gene_Ensembl_ID":"ENSG00000139618","Gene_symbol":"BRCA2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uveal Melanoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000616","MONDO":"MONDO_0006486","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.38,"TPM_sd":0.36,"TPM_min":0,"TPM_25th_percentile":0.11,"TPM_median":0.25,"TPM_75th_percentile":0.6,"TPM_max":1.54}]